文献速递消化道肿瘤放疗放疗物理与技术

胃肠道恶性肿瘤的自适应放疗综述

Adaptive radiotherapy for gastrointestinal malignancies.
PubMed 文献 · Radiat Oncol · 2025-11-20

本文综述自适应放疗(ART)在胃肠道肿瘤中的应用,包括在线和离线ART。在线ART在胰腺癌SBRT中支持安全剂量递增,在肝癌和腹部寡转移SBRT中支持单次照射;在线和离线ART可能降低肛管癌和直肠癌毒性。人工智能与直接到设备工作流程的整合有望提高效率并推广ART。

要点

  • 在线ART支持局部晚期胰腺癌SBRT的安全剂量递增治疗。
  • ART支持肝癌和腹部寡转移SBRT及单次腹部SBRT的安全实施。
  • 在线和离线ART可能降低肛管癌和直肠癌患者的毒性。

核心结论

  • ART是不断扩展的放疗范式,根据患者解剖变化调整治疗计划,已成功整合到多种胃肠道肿瘤治疗中。
  • 胰腺癌、肝癌和下消化道肿瘤等工作流程的成功实施及多中心临床试验的纳入,提示ART将继续在胃肠道放射肿瘤学中发挥关键作用。

研究设计与样本

  • 本文为叙述性综述,回顾在线和离线ART在胃肠道肿瘤中的适应证。

主要发现

  • 在线ART在胰腺癌立体定向体部放疗(SBRT)中起关键作用,多种ART工作流程证明ART允许对局部晚期胰腺癌进行安全剂量递增治疗。
  • ART在肝癌和腹部寡转移SBRT中起关键作用,并允许安全实施单次腹部SBRT。
  • 在线和离线ART工作流程均显示可能降低肛管癌和直肠癌患者的毒性。
  • 人工智能与直接到设备工作流程的改进整合有望提高ART整体流程效率,促进其在胃肠道放射肿瘤学中更广泛采用。

临床怎么用

  • 在胰腺癌SBRT中可考虑在线ART以支持安全剂量递增。
  • 在肝癌和腹部寡转移SBRT中可应用ART以安全实施单次照射。
  • 在肛管癌和直肠癌中,在线或离线ART工作流程可能有助于降低毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adaptive radiotherapy (ART) is an advanced form of image-guided radiotherapy that involves the re-contouring and re-planning of a patient's treatment plan, either while the patient is on the table (online) or in between fractions (offline). ART allows for the adjustment of a treatment plan to respect a patient's changes in internal anatomy, something that is critical in the treatment of gastrointestinal (GI) malignancies in which the mobile and radiosensitive GI tract plays a key role in driving toxicity. Herein we review the indications for both online and offline ART in GI cancers. MAIN TEXT: Online ART plays a critical role in the treatment of pancreatic cancer when using stereotactic body radiotherapy (SBRT). A variety of ART workflows have demonstrated that ART allows for the safe dose-escalated treatment of locally advanced pancreatic cancer. In addition to pancreatic cancer, there are now a bevy of data demonstrating that ART plays a key role in the treatment of liver cancers and abdominal oligometastases when using SBRT and allows for the safe delivery of single-fraction abdominal SBRT. While lower GI cancers are generally not treated with SBRT-like doses, both online and offline ART workflows have been shown to potentially reduce toxicity in patients with anal and rectal cancers. Improved integration of artificial intelligence and direct-to-unit workflows in ART hold promise that the overall process can become more efficient, allowing for more widespread adoption in GI radiation oncology. CONCLUSIONS: ART is an expanding radiotherapy paradigm in which a patient's treatment plan is adjusted to match observed changes in patient anatomy and has been successfully incorporated into the treatment of a variety of GI cancers. The successful implementation of workflows in pancreatic cancer, liver cancers, and lower GI cancers, amongst others, as well as incorporation into multi-center clinical trials, suggest that ART will continue to play a critical role of GI radiation oncology for years to come. As improvements in efficiency and access allow for increasing use of ART world-wide, we predict that ART will continue to play a critical part in the management of patients with GI malignancies.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Schiff JP, Guevara B, Ahari A, et al. Adaptive radiotherapy for gastrointestinal malignancies. Radiat Oncol. 2025. PMID: 41261391. doi:10.1186/s13014-025-02722-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。